Canine Diarrhea of Unknown Cause – NAVLE Study Guide

Overview and Clinical Importance

Diarrhea of unknown cause is one of the most common presenting complaints in canine practice and represents a significant diagnostic challenge. This term encompasses cases where the underlying etiology is not immediately apparent after initial assessment, requiring a systematic diagnostic approach. Understanding the classification, pathophysiology, and stepwise workup of diarrhea is essential for NAVLE success and clinical practice.

The gastrointestinal tract serves critical functions including digestion, nutrient absorption, water and electrolyte balance, and immune surveillance. Dysfunction at any level can manifest as diarrhea, defined as an increase in frequency, fluidity, or volume of fecal output. Chronic diarrhea (lasting greater than 3 weeks) requires a more extensive diagnostic approach compared to acute, self-limiting cases.

Classification of Diarrhea

Acute vs. Chronic Diarrhea

Acute diarrhea is present for less than 2-3 weeks and is often self-limiting, commonly caused by dietary indiscretion, infectious agents, or stress. Most cases resolve with symptomatic treatment including fluid support and dietary modification.

Chronic diarrhea persists for greater than 3 weeks or is intermittently present for more than 3 weeks. This requires a systematic diagnostic workup as it suggests an underlying disease process that will not self-resolve.

Small Bowel vs. Large Bowel Diarrhea

The first critical step in evaluating diarrhea is localizing the source to small intestine, large intestine, or mixed bowel disease. This distinction fundamentally changes the diagnostic approach and differential diagnosis list.

Major Differential Diagnoses

Chronic Enteropathies Classification

Modern veterinary gastroenterology classifies chronic enteropathies based on response to therapy:

• Food-Responsive Enteropathy (FRE): Most common type; responds to dietary modification alone
• Antibiotic-Responsive Diarrhea (ARD): Responds to antimicrobial therapy; German Shepherds predisposed
• Steroid-Responsive/Immunosuppressant-Responsive Enteropathy: Requires immunosuppressive therapy; often called IBD
• Non-Responsive Enteropathy: Fails to respond to diet, antibiotics, or immunosuppression; poor prognosis

Inflammatory Bowel Disease (IBD)

Inflammatory bowel disease is a chronic condition characterized by persistent GI inflammation without identifiable underlying cause. It is a diagnosis of exclusion requiring histopathologic confirmation.

Pathophysiology: Abnormal immune response to luminal antigens (dietary, bacterial, environmental) in genetically susceptible individuals. Results in infiltration of the intestinal wall with inflammatory cells.

Histologic Types: Lymphocytic-plasmacytic enteritis (most common), eosinophilic enteritis, granulomatous enteritis (rare)

Clinical Signs: Chronic intermittent vomiting and/or diarrhea, weight loss, decreased appetite, variable severity. Middle-aged dogs most commonly affected.

Diagnostic Findings: Abdominal ultrasound may show intestinal wall thickening, loss of normal wall layering, or mesenteric lymphadenopathy. Definitive diagnosis requires intestinal biopsy showing inflammatory infiltrates per WSAVA histopathologic standards.

IBD Treatment Options

Exocrine Pancreatic Insufficiency (EPI)

Exocrine pancreatic insufficiency results from inadequate production of digestive enzymes by the pancreas. Clinical signs do not manifest until greater than 90% of secretory capacity is lost.

Etiology: Pancreatic acinar atrophy (most common in German Shepherds, Rough Collies, Eurasiers - likely immune-mediated) or chronic pancreatitis (other breeds)

Classic Triad: Polyphagia + weight loss + voluminous, pale, fatty stool (steatorrhea)

Other Clinical Signs: Borborygmi, flatulence, coprophagia, poor coat quality, greasy perianal region

Diagnosis: Serum trypsin-like immunoreactivity (TLI) is the gold standard. Fasting sample required. TLI less than or equal to 2.5 mcg/L is diagnostic; 2.5-5.7 mcg/L is equivocal (repeat in 1 month).

Treatment: Pancreatic enzyme replacement therapy (PERT) - powdered form preferred over tablets/capsules. Dose: 1 teaspoon per 10 kg body weight with each meal. Fresh raw pancreas (30-90g) can substitute. Cobalamin (B12) supplementation essential in most cases. Feed highly digestible, low-fiber, moderate-fat diet.

Protein-Losing Enteropathy (PLE)

Protein-losing enteropathy is a syndrome of excessive protein loss through the intestinal mucosa, resulting in panhypoproteinemia (low albumin AND globulins). This distinguishes it from protein-losing nephropathy (albumin loss only).

Common Causes: Intestinal lymphangiectasia (most common), severe IBD, GI lymphoma, histoplasmosis, GI ulceration

Breed Predispositions: Yorkshire Terriers, Soft-Coated Wheaten Terriers, Norwegian Lundehunds, Rottweilers, Chinese Shar-Peis, Maltese

Clinical Signs: Chronic diarrhea (may be absent in 30% of cases), weight loss, peripheral edema, ascites, pleural effusion, lethargy

Laboratory Findings: Hypoalbuminemia (less than 2.0 g/dL), hypoglobulinemia, hypocholesterolemia, hypocalcemia (due to low albumin-bound calcium), lymphopenia (with lymphangiectasia), hypocobalaminemia

Ultrasound Findings: Intestinal lymphangiectasia shows characteristic hyperechoic mucosal striations ('tiger stripe' appearance), intestinal wall thickening, mesenteric lymphadenopathy

Treatment Approach: Ultra-low-fat diet (less than 15% fat by ME) is cornerstone for lymphangiectasia. Home-cooked diets formulated by veterinary nutritionist often necessary. Prednisone/prednisolone for inflammatory component. Cobalamin supplementation. Antithrombotic therapy (aspirin or clopidogrel) - 10% of PLE dogs develop thromboembolic complications due to antithrombin III loss.

Memory Aid - PLE Breeds: 'YUMMY SOW RUNS' = Yorkshire terrier, Maltese, Soft-coated Wheaten, Rottweiler, Norwegian Lundehund, Shar-pei

Systematic Diagnostic Approach

Step 1: History and Physical Examination

A thorough history is essential and should address:

• Duration and character of diarrhea (acute vs. chronic, small vs. large bowel)
• Complete dietary history including treats, supplements, table scraps, and potential indiscretions
• Previous diet changes and response
• Deworming history and products used
• Travel history, boarding, exposure to other animals
• Concurrent signs: vomiting, appetite changes, weight loss
• Previous treatments and response

Step 2: Initial Diagnostics

Fecal Examination

Multiple fecal examinations are CRITICAL as the first diagnostic step:

• Zinc sulfate centrifugal flotation: Most sensitive method; detects Giardia cysts and most parasite eggs
• Direct fecal smear: Fresh feces with saline; may visualize Giardia trophozoites
• Giardia antigen ELISA (SNAP test): 95% sensitivity, 99% specificity; detects antigen even without cyst shedding
• Fecal antigen testing: Detects hookworm, roundworm, whipworm antigens before eggs are shed

Exam Focus: Whipworms (Trichuris vulpis) are difficult to diagnose - they shed eggs intermittently and float poorly in standard solutions. Always perform therapeutic deworming with fenbendazole (50 mg/kg x 3 days) in any dog with chronic large bowel diarrhea, regardless of fecal results!

Baseline Laboratory Tests

• Complete Blood Count (CBC): Evaluate for anemia (chronic GI blood loss), eosinophilia (parasites, eosinophilic enteritis), lymphopenia (lymphangiectasia)
• Serum Chemistry Panel: Total protein, albumin, globulins, liver enzymes, kidney values, cholesterol, electrolytes
• Urinalysis: Rule out proteinuria (protein-losing nephropathy)

Step 3: GI Function Tests

Step 4: Imaging

Abdominal Radiographs: Low yield for chronic diarrhea but useful to rule out obstruction, masses, or foreign bodies. May show intestinal gas distension or loss of serosal detail with effusion.

Abdominal Ultrasound: More sensitive than radiographs. Evaluates intestinal wall thickness and layering, mesenteric lymph nodes, masses, intussusception. Normal canine small intestinal wall thickness is 2-5 mm. Look for hyperechoic mucosal striations in lymphangiectasia, loss of wall layering in neoplasia/severe IBD.

Step 5: Dietary Trial

Before proceeding to intestinal biopsy, a properly conducted dietary trial is essential:

• Duration: 2-4 weeks for GI signs (8-12 weeks for dermatologic signs)
• Diet Options: Hydrolyzed protein diet (first choice) OR novel protein diet based on thorough diet history
• Strict Compliance: NO treats, table scraps, flavored medications, or other foods
• Response: Improvement within 1-4 weeks suggests food-responsive enteropathy

Step 6: Intestinal Biopsy

Required for definitive diagnosis of IBD, lymphoma, lymphangiectasia, and other infiltrative diseases. Can be obtained via:

• Endoscopy: Minimally invasive; mucosal biopsies only; limited to duodenum and colon/ileum
• Surgical (Laparotomy/Laparoscopy): Full-thickness biopsies; can sample jejunum and mesenteric lymph nodes; better for focal lesions

Treatment Principles

Dietary Management

Supportive Care

• Cobalamin Supplementation: Injectable or oral; 250-1500 mcg depending on size; weekly then monthly maintenance
• Probiotics: May help modulate intestinal microbiome; use veterinary-specific products
• Fluid Therapy: For dehydrated patients; correct electrolyte imbalances
• Antiemetics: Maropitant (Cerenia) 2 mg/kg PO/SQ q24h if vomiting present